Cargando…
AAV1.NT‐3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia
BACKGROUND: Sarcopenia, an age‐related loss of muscle mass, is a critical factor that affects the health of the older adults. The SOD1KO mouse is deficient of Cu/Zn superoxide dismutase, used as an accelerated aging model. We previously showed that NT‐3 improves muscle fibre size by activating the m...
Autores principales: | Tong, Lingying, Ozes, Burcak, Moss, Kyle, Myers, Morgan, Ridgley, Alicia, Sahenk, Zarife |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570084/ https://www.ncbi.nlm.nih.gov/pubmed/37553101 http://dx.doi.org/10.1002/jcsm.13303 |
Ejemplares similares
-
AAV1.NT-3 gene therapy prevents age-related sarcopenia
por: Ozes, Burcak, et al.
Publicado: (2023) -
AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in Gars(P278KY/+) mice
por: Ozes, Burcak, et al.
Publicado: (2021) -
AAV1.NT-3 gene therapy for X-linked Charcot–Marie–Tooth neuropathy type 1
por: Ozes, Burcak, et al.
Publicado: (2021) -
Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1
por: Sahenk, Zarife, et al.
Publicado: (2021) -
AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy
por: Sahenk, Zarife, et al.
Publicado: (2014)